ICU病房鲍曼不动杆菌的分离率及耐药性分析.pdfVIP

论 著 2 0 14 年6 月 ICU 病房鲍曼不动杆菌的分离率及耐药性分析 王彬 ( 沈阳市第二中医医院检验科 110101) 【 】目的 : 了解ICU 病房鲍曼不动杆菌 （ABA）的临床分离率及耐药性趋势，指导临床采取有效的预防和控制感染的措施，合理的使用抗菌药物。方法 :2005 摘要 年 -2013 年 ICU 病房临床标本中分离的鲍曼不动杆菌的分离率及耐药性回顾性分析；采用法国生物梅里埃公司VITEK2Compact 全自动微生物分析系统进行鉴定和药敏 试验，用WHONET5.6 软件进行数据统计分析。结果 :鲍曼不动杆菌的临床分离率及耐药性趋势逐年增高，多重耐药和泛耐药比例呈上升趋势。结论 :本研究显示 为避免盲目应用抗菌药物带来的选择压力，根据药敏合理使用抗生素，加强对 ICU 病房的消毒与隔离，加强医院感染的管理，这样可以有效的控制鲍曼不动杆菌在 医院的定植和播散。 【 】鲍曼不动杆菌 抗菌药物 耐药性 关键词 【 】R37 【 】A 【 】1672-5085 （2014）23-0088-02 中图分类号 文献标识码 文章编号 Separation rate and drug resistance of acinetobacter baumannii in the ICU wards Wang Bin (Laboratory of Second Chinese Medicine Hospital in Shenyang,Shenyang 110101,China) 【Abstract】Objective To understand acinetobacter baumannii(ABA) clinical separation rate and drug resistance trend in ICU ward, it also used to guide clinical taking effective measures to prevent infection and rational use of antimicrobial agents. Methods Separation rate and drug resistance of acinetobacter baumannii in the clinical specimens of ICU wards from 2005 to 2013 were retrospectively analyzed; Using VITEK2 Compact automatic microbial analysis system to identification and drug sensitive test, and Using WHONET5.6 software analysis for data statistics and analysis. Results it was obvious that acinetobacter baumannii(ABA) clinical separation rate and drug resistance trend was increasing year by year and multiple drug resistance and Pan drug Resistant Strains ratio was on the rise. Conclusions This research shows that antibiotics should be rationally used to avoid blind application of antimicrobial selection pressure, strengthening the disinfection and isolation of the ICU ward and the management of hospital infection, so the acinet